Background and purpose Neuroinflammation plays a role in the aetiopathogenesis of Alzheimer's disease (AD). Triggering receptor expressed on myeloid cells 2 (TREM2), a cell surface receptor of the immunoglobulin superfamily, seems to have protective anti‐inflammatory activity in AD. Methods Triggering receptor expressed on myeloid cells 2 expression was analysed in peripheral blood mononuclear cells from healthy subjects (CT) and from patients with either AD or mild cognitive impairment (MCI). MCI patients were re‐evaluated at a 2‐year follow‐up to investigate their progression to AD (MCI‐AD) or lack thereof (MCI‐MCI). Results Triggering receptor expressed on myeloid cells 2 gene expression was higher in AD than CT patients, but was highest in MCI. At recruitment TREM2 levels were higher in MCI‐AD than in MCI‐MCI, and in MCI‐AD were higher initially than at follow‐up. TREM2 displayed a moderate degree of sensitivity and specificity for identifying MCI‐AD in all MCI patients. Our data showed higher TREM2 levels in allele ε4 of apolipoprotein E (ApoE ε4) carriers than non‐carriers in MCI and particularly in MCI‐AD. Conclusions These data seem to confirm the protective role of TREM2 in the pre‐clinical stage of AD. Upregulation of TREM2 in MCI‐AD could be a mechanism to counteract the activation of neuroinflammatory processes. It is possible that TREM2 and ApoE ε4 interact synergistically in the pre‐clinical stage of AD. Therefore, TREM2 may be useful as an early peripheral biomarker for the development of AD.

Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients that progress into Alzheimer's disease / M. Casati, E. Ferri, C. Gussago, P. Mazzola, C. Abbate, G. Bellelli, D. Mari, M. Cesari, B. Arosio. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 25:6(2018 Jan 27), pp. 805-810. [10.1111/ene.13583]

Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients that progress into Alzheimer's disease

M. Casati;E. Ferri;C. Gussago;C. Abbate;D. Mari;M. Cesari;B. Arosio
2018-01-27

Abstract

Background and purpose Neuroinflammation plays a role in the aetiopathogenesis of Alzheimer's disease (AD). Triggering receptor expressed on myeloid cells 2 (TREM2), a cell surface receptor of the immunoglobulin superfamily, seems to have protective anti‐inflammatory activity in AD. Methods Triggering receptor expressed on myeloid cells 2 expression was analysed in peripheral blood mononuclear cells from healthy subjects (CT) and from patients with either AD or mild cognitive impairment (MCI). MCI patients were re‐evaluated at a 2‐year follow‐up to investigate their progression to AD (MCI‐AD) or lack thereof (MCI‐MCI). Results Triggering receptor expressed on myeloid cells 2 gene expression was higher in AD than CT patients, but was highest in MCI. At recruitment TREM2 levels were higher in MCI‐AD than in MCI‐MCI, and in MCI‐AD were higher initially than at follow‐up. TREM2 displayed a moderate degree of sensitivity and specificity for identifying MCI‐AD in all MCI patients. Our data showed higher TREM2 levels in allele ε4 of apolipoprotein E (ApoE ε4) carriers than non‐carriers in MCI and particularly in MCI‐AD. Conclusions These data seem to confirm the protective role of TREM2 in the pre‐clinical stage of AD. Upregulation of TREM2 in MCI‐AD could be a mechanism to counteract the activation of neuroinflammatory processes. It is possible that TREM2 and ApoE ε4 interact synergistically in the pre‐clinical stage of AD. Therefore, TREM2 may be useful as an early peripheral biomarker for the development of AD.
Alzheimer's disease; TREM2; mild cognitive impairment; neuroinflammation; peripheral biomarker
Settore MED/09 - Medicina Interna
Article (author)
File in questo prodotto:
File Dimensione Formato  
Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients that progr.pdf

embargo fino al 30/03/2019

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 296.27 kB
Formato Adobe PDF
296.27 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/550573
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 31
social impact